Episode Details

Stereotaxis is on a rocket ship—its Q2 earnings reveal explosive growth fueled by a game-changing new catheter, a digital surgery cockpit, and a robotic system poised to scale globally. The MAGiC catheter is turning heads in the OR, boosting adoption and driving $1M+ in quarterly catheter revenue as demand outpaces supply. Their Synchrony system is already generating $1M+ in revenue per quarter without heavy sales efforts. With GenesisX set to remove X-ray compatibility barriers and first U.S. installations coming this fall, Stereotaxis is clearing the path for mass-market adoption. Long-term bets include wireless robots, pulsed field ablation, AI, and expansion into cardiology and neurointerventional fields. Recurring revenue is projected to hit $7M Q3 and $8M Q4, with cash flow profitability targeted for early 2027.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/c8eb048585edb413